Single User License
INR 168900
Site License
INR 337800
Corporate User License
INR 506700

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Xerostomia Global Clinical Trials Review, H1

Xerostomia Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Xerostomia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Xerostomia Global Clinical Trials Review, H1, 2015" provides an overview of Xerostomia clinical trials scenario. This report provides top line data relating to the clinical trials on Xerostomia . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Xerostomia 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Unaccomplished Trials of Xerostomia 24

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Xerostomia Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Boehringer Ingelheim GmbH 31

Clinical Trial Overview of Boehringer Ingelheim GmbH 31

Worldwide Clinical Trials, Inc. 32

Clinical Trial Overview of Worldwide Clinical Trials, Inc. 32

Parion Sciences, Inc. 33

Clinical Trial Overview of Parion Sciences, Inc. 33

Daiichi Sankyo Company, Limited 34

Clinical Trial Overview of Daiichi Sankyo Company, Limited 34

Acacia Pharma Limited 35

Clinical Trial Overview of Acacia Pharma Limited 35

GlaxoSmithKline Plc 36

Clinical Trial Overview of GlaxoSmithKline Plc 36

General Drugs House Co., Ltd. 37

Clinical Trial Overview of General Drugs House Co., Ltd. 37

CEDRA Corporation 38

Clinical Trial Overview of CEDRA Corporation 38

Camurus AB 39

Clinical Trial Overview of Camurus AB 39

Calabar AB 40

Clinical Trial Overview of Calabar AB 40

Clinical Trial Overview of Top Institutes / Government 41

Alberta Health Services 41

Clinical Trial Overview of Alberta Health Services 41

American Academy of Otolaryngology Head and Neck Surgery 42

Clinical Trial Overview of American Academy of Otolaryngology Head and Neck Surgery 42

Asan Medical Center 43

Clinical Trial Overview of Asan Medical Center 43

Centre Francois Baclesse 44

Clinical Trial Overview of Centre Francois Baclesse 44

Charite-Universitatsmedizin Berlin 45

Clinical Trial Overview of Charite-Universitatsmedizin Berlin 45

Children's Hospital Boston 46

Clinical Trial Overview of Children's Hospital Boston 46

Dental Innovation Foundation 47

Clinical Trial Overview of Dental Innovation Foundation 47

Department of Health, UK 48

Clinical Trial Overview of Department of Health, UK 48

Erasmus MC 49

Clinical Trial Overview of Erasmus MC 49

Georgia Regents University 50

Clinical Trial Overview of Georgia Regents University 50

Five Key Clinical Profiles 51

Appendix 76

Abbreviations 76

Definitions 76

Research Methodology 77

Secondary Research 77

About GlobalData 78

Contact Us 78

Disclaimer 78

Source 79

List of Figures

Xerostomia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Xerostomia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Xerostomia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Xerostomia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Xerostomia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Xerostomia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Xerostomia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Xerostomia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials, G7 Countries (%), 2015* 15

Xerostomia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Xerostomia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials, E7 Countries (%), 2015* 18

Xerostomia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Xerostomia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20

Xerostomia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21

Xerostomia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Xerostomia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Xerostomia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Xerostomia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Xerostomia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Xerostomia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Xerostomia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 77

List of Tables

Xerostomia Therapeutics, Global, Clinical Trials by Region, 2015* 7

Xerostomia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Xerostomia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Xerostomia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Xerostomia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Xerostomia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Xerostomia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Xerostomia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials, G7 Countries (%), 2015* 15

Xerostomia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Xerostomia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials, E7 Countries (%), 2015* 18

Xerostomia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Xerostomia Therapeutics, Global, Clinical Trials by Phase, 2015* 20

Xerostomia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21

Xerostomia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Xerostomia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Xerostomia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24

Xerostomia Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Xerostomia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Xerostomia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Xerostomia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Xerostomia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Xerostomia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2015* 31

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Worldwide Clinical Trials, Inc., 2015* 32

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Parion Sciences, Inc., 2015* 33

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 34

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Acacia Pharma Limited, 2015* 35

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 36

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by General Drugs House Co., Ltd., 2015* 37

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by CEDRA Corporation, 2015* 38

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Camurus AB, 2015* 39

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Calabar AB, 2015* 40

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2015* 41

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by American Academy of Otolaryngology Head and Neck Surgery, 2015* 42

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 43

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Francois Baclesse, 2015* 44

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite-Universitatsmedizin Berlin, 2015* 45

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2015* 46

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dental Innovation Foundation, 2015* 47

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 48

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 49

Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgia Regents University, 2015* 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Boehringer Ingelheim GmbH

Worldwide Clinical Trials, Inc.

Parion Sciences, Inc.

Daiichi Sankyo Company, Limited

Acacia Pharma Limited

GlaxoSmithKline Plc

General Drugs House Co., Ltd.

CEDRA Corporation

Camurus AB

Calabar AB

Xerostomia Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Xerostomia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com